In order to get a ready made 2.5mg of oxycodone instead of nursing have to split, our pharmacy splits the 5mg tab and then unit-doses that as "Oxycodone 2.5mg." We are looking for feed back as to what the unit dose label should say. the names that we are between is just "Oxycodone 2.5mg Tablet" or
"Oxycodone 2.5mg (1/2 of a 5mg tablet)"

What is clearer?
What do you do in your facility to label split tabs?

Thank you

Hi everyone,

How do your sites draw up and deliver bevacizumab for intravitreal administration for retinopathy of prematurity? We have a NICU protocol with a dose of 0.05 mL of bevacizumab drawn up in a 1 mL syringe and delivered to the unit. The dose to be administered is 0.025 mL. However, since this dose is very small, our pharmacy dispenses 0.05 mL for the proceduralist to administer half of the dispensed dose. There are potential errors associated with this practice, and we are evaluating our workflow.

Hello,
Do any of your organizations use the Mini-Bag Plus system with Zosyn vials? Have you had reports of product returning to the vials after initially mixing?

We are whittling down pir 585 line items requiring dual check. We recently removed SQ insulin and are now tackling TPN/PPN.
Are you requiring a dual check for TPN or PPN ?
Y/N

thank you !
Laura

Hello,

I wanted help in understand what the recommendation is when it comes to use of the amiodarone in-line filters-does anyone know if is it recommended to use a new filter each time or is there a shelf life of the filter (eg: 1 filter per 96 hrs). Unfortunately,Manufacturer was not able to provide clarification on it.

Thank you.

Hello, some providers at our facility are requesting to turn off medication interaction alerts for several inactive ingredients (some eg: YELLOW DYE, CI PIGMENT BLUE 63,RED DYE,BENZYL ALCOHOL,BRILLIANT BLUE FCF,SACCHARIN,SODIUM BENZOATE, WATER, STERILE)

How does your institution determine what alerts are appropriate to turn off/silence?

Thank you.

Abhi

Hello. I'm wondering if anyone has standards of practice they are willing to share around the use of Orthopedic / Joint Antibiotics. For example, guidelines with patient selection, dosing, monitoring, etc.
We are seeing clinically relevant absorption and are concerned for possible ADRs.
Thanks so much.

Good afternoon,

Does anyone have policy or standardized monitoring (i.e. critical care monitoring for 6 hours) if a patient has an extravasation of a sedative, paralytic, vasopressor, etc due to concern for ADR post extravasation related to variable absorption/effect?

Hello,

Our health system is considering switching our ambulatory 5-FU infusions to be dispensed in elastomeric pumps from CADD pumps due to reports of spills, disconnects and alarms.

There is some literature out there citing spills occurring upto 40% of the time as well as excess fluid being present at disconnect upto 40% of the time (sample sizes were small).

Curious, if you use elastomeric pumps in your oncology space if this is your experience? Also, what failures do you experience when using these pumps.

Your time and response is greatly appreciated!